Determinants of RNA-Dependent RNA Polymerase (In)fidelity Revealed by Kinetic Analysis of the Polymerase Encoded by a Foot-and-Mouth Disease Virus Mutant with Reduced Sensitivity to Ribavirin

ABSTRACT A mutant poliovirus (PV) encoding a change in its polymerase (3Dpol) at a site remote from the catalytic center (G64S) confers reduced sensitivity to ribavirin and forms a restricted quasispecies, because G64S 3Dpol is a high-fidelity enzyme. A foot-and-mouth disease virus (FMDV) mutant that encodes a change in the polymerase catalytic site (M296I) exhibits reduced sensitivity to ribavirin without restricting the viral quasispecies. In order to resolve this apparent paradox, we have established a minimal kinetic mechanism for nucleotide addition by wild-type (WT) FMDV 3Dpol that permits a direct comparison to PV 3Dpol as well as to FMDV 3Dpol derivatives. Rate constants for correct nucleotide addition were on par with those of PV 3Dpol, but apparent binding constants for correct nucleotides were higher than those observed for PV 3Dpol. The A-to-G transition frequency was calculated to be 1/20,000, which is quite similar to that calculated for PV 3Dpol. The analysis of FMDV M296I 3Dpol revealed a decrease in the calculated ribavirin incorporation frequency (1/8,000) relative to that (1/4,000) observed for the WT enzyme. Unexpectedly, the A-to-G transition frequency was higher (1/8,000) than that observed for the WT enzyme. Therefore, FMDV selected a polymerase that increases the frequency of the misincorporation of natural nucleotides while specifically decreasing the frequency of the incorporation of ribavirin nucleotide. These studies provide a mechanistic framework for understanding FMDV 3Dpol structure-function relationships, provide the first direct analysis of the fidelity of FMDV 3Dpol in vitro, identify the β9-α11 loop as a (in)fidelity determinant, and demonstrate that not all ribavirin-resistant mutants will encode high-fidelity polymerases.

[1]  Guobin Luo,et al.  Single-molecule and ensemble fluorescence assays for a functionally important conformational change in T7 DNA polymerase , 2007, Proceedings of the National Academy of Sciences.

[2]  D. Olsen,et al.  Nucleoside analog inhibitors of hepatitis C virus replication. , 2006, Infectious disorders drug targets.

[3]  Smita S Patel,et al.  Transient State Kinetics of Transcription Elongation by T7 RNA Polymerase*♦ , 2006, Journal of Biological Chemistry.

[4]  M. Vignuzzi,et al.  Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population , 2006, Nature.

[5]  C. Cameron,et al.  Challenges for the Development of Ribonucleoside Analogues as Inducers of Error Catastrophe , 2004, Antiviral chemistry & chemotherapy.

[6]  A. Thompson,et al.  Stabilization of poliovirus polymerase by NTP binding and fingers-thumb interactions. , 2007, Journal of molecular biology.

[7]  Julie K. Pfeiffer,et al.  A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Mitsuya,et al.  Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance , 2006, Cellular and Molecular Life Sciences.

[9]  M. Götte Inhibition of HIV-1 reverse transcription: basic principles of drug action and resistance , 2004, Expert review of anti-infective therapy.

[10]  J. Arnold,et al.  Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective☆ , 2004, Virus Research.

[11]  Julie K. Pfeiffer,et al.  Ribavirin Resistance in Hepatitis C Virus Replicon-Containing Cell Lines Conferred by Changes in the Cell Line or Mutations in the Replicon RNA , 2005, Journal of Virology.

[12]  M. Vignuzzi,et al.  Remote Site Control of an Active Site Fidelity Checkpoint in a Viral RNA-dependent RNA Polymerase* , 2005, Journal of Biological Chemistry.

[13]  J. Arnold,et al.  Nucleic Acid Polymerase Fidelity and Viral Population Fitness , 2008 .

[14]  Bo Oberg Rational design of polymerase inhibitors as antiviral drugs. , 2006, Antiviral research.

[15]  E. Domingo,et al.  The structure of a protein primer–polymerase complex in the initiation of genome replication , 2006, The EMBO journal.

[16]  Marco Vignuzzi,et al.  Engineering attenuated virus vaccines by controlling replication fidelity , 2008, Nature Medicine.

[17]  E. Domingo,et al.  Structure of Foot-and-Mouth Disease Virus RNA-dependent RNA Polymerase and Its Complex with a Template-Primer RNA* , 2004, Journal of Biological Chemistry.

[18]  C. Cameron,et al.  RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Arnold,et al.  Poliovirus RNA-dependent RNA polymerase (3Dpol): kinetic, thermodynamic, and structural analysis of ribonucleotide selection. , 2004, Biochemistry.

[20]  E. Domingo Antiviral strategy on the horizon , 2005 .

[21]  L. Loeb,et al.  Viral error catastrophe by mutagenic nucleosides. , 2004, Annual review of microbiology.

[22]  J. Arnold,et al.  Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub). , 2000, The Journal of biological chemistry.

[23]  M. Wainberg,et al.  Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[24]  L. Menéndez-Arias Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases. , 2002, Progress in nucleic acid research and molecular biology.

[25]  M. Lai,et al.  Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. , 2003, Biochemistry.

[26]  Kenneth A. Brown,et al.  Problems and Perspectives , 2009, The Search for Security in the Pacific 1901-1914.

[27]  E. Domingo,et al.  Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. , 2003, Virology.

[28]  E. Domingo,et al.  Origin and Evolution of Viruses , 2010, Virus Genes.

[29]  Identification of a Ribavirin‐resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy , 2003, Hepatology.

[30]  V. Stollar,et al.  Antiviral therapy targeting viral polymerase. , 2006, Current pharmaceutical design.

[31]  T. Ahola,et al.  Inhibitors of virus replication: recent developments and prospects , 2004, Applied Microbiology and Biotechnology.

[32]  J. Arnold,et al.  Poliovirus RNA-dependent RNA Polymerase (3Dpol) , 2000, The Journal of Biological Chemistry.

[33]  C. Isel,et al.  Nucleoside and nucleotide inhibitors of HIV-1 replication , 2006, Cellular and Molecular Life Sciences CMLS.

[34]  Carroll Ss,et al.  Nucleoside Analog Inhibitors of Hepatitis C Virus Replication , 2006 .

[35]  C. Cameron,et al.  Mechanisms of action of ribavirin against distinct viruses , 2005, Reviews in medical virology.

[36]  J. Arnold,et al.  The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.

[37]  E. Domingo,et al.  Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. , 2005, Journal of molecular biology.

[38]  A. Thompson,et al.  Structural basis for proteolysis‐dependent activation of the poliovirus RNA‐dependent RNA polymerase , 2004, The EMBO journal.

[39]  J. Arnold,et al.  Poliovirus RNA-dependent RNA polymerase (3Dpol): pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+. , 2004, Biochemistry.

[40]  E. Domingo,et al.  Sequential structures provide insights into the fidelity of RNA replication , 2007, Proceedings of the National Academy of Sciences.

[41]  M. Kukhanova,et al.  Design of anti-HIV compounds: from nucleoside to nucleoside 5'-triphosphate analogs. Problems and perspectives. , 2000, Current pharmaceutical design.

[42]  J. Arnold,et al.  Structure-function relationships among RNA-dependent RNA polymerases. , 2008, Current topics in microbiology and immunology.

[43]  E. Domingo,et al.  Foot-and-Mouth Disease Virus Mutant with Decreased Sensitivity to Ribavirin: Implications for Error Catastrophe , 2006, Journal of Virology.

[44]  Julie K. Pfeiffer,et al.  Increased Fidelity Reduces Poliovirus Fitness and Virulence under Selective Pressure in Mice , 2005, PLoS pathogens.

[45]  M. Götte Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation. , 2006, Current pharmaceutical design.

[46]  Kenneth A. Johnson,et al.  A new paradigm for DNA polymerase specificity. , 2006, Biochemistry.

[47]  Jianping Ding,et al.  Targeting HIV reverse transcriptase for anti-AIDS drug design: structural and biological considerations for chemotherapeutic strategies. , 1996, Drug design and discovery.